Scientific references immune system
- McCarty MF. “Clinical potential of Spirulina as a source of phycocyanobilin”. Journal of Medicinal Food 10.4 (2007): 566-570. https:// www.ncbi.nlm.nih.gov/pubmed/18158824
- Torres-Duran PV., et al. “Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican popula- tion: a preliminary report”. Lipids in Health and Disease 6 (2007): 33. https://www.ncbi.nlm.nih.gov/pubmed/18039384
- Nagaoka S., et al. “A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concen- trate in rats”. The Journal of Nutrition 135.10 (2005): 2425-2430. https://www.ncbi.nlm.nih.gov/pubmed/16177207
- Saravanan P., et al. “Cardiovascular effects of marine omega-3 fatty acids”. Lancet 376.9740 (2010): 540-550. https://www.ncbi.nlm. nih.gov/pubmed/20638121
- Simopoulos AP. “Omega-3 fatty acids in inflammation and autoimmune diseases”. Journal of the American College of Nutrition 21.6 (2002): 495-505. https://www.ncbi.nlm.nih.gov/pubmed/12480795
- Whelan J. “Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potential health benefits”. The Journal of Nutrition 139.1 (2009): 5-10. https://www.ncbi.nlm.nih.gov/pubmed/19056654
- Kalafati M., et al. “Ergogenic and antioxidant effects of spirulina supplementation in humans”. Medicine and Science in Sports and Exercise 42.1 (2010): 142-151. https://www.ncbi.nlm.nih.gov/pubmed/20010119
- Hirahashi T., et al. “Activation of the human innate immune system by Spirulina: augmentation of interferon production and NK cyto- toxicity by oral administration of hot water extract of Spirulina platensis”. International Immunopharmacology 2.4 (2002): 423-434. https://www.ncbi.nlm.nih.gov/pubmed/11962722
- Balachandran P., et al. “Toll-like receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in mice”. International Immunopharmacology 6.12 (2006): 1808-1814. https://www.ncbi.nlm.nih.gov/pubmed/17052671
- Akao Y., et al. “Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice”. Cancer Science 100.8 (2009): 1494-1501. https://www.ncbi.nlm.nih.gov/pubmed/19432881
- Pugh N., et al. “Isolation of three high molecular weight polysaccharide preparations with potent immunostimulatory activity from Spirulina platensis, aphanizomenon flos-aquae and Chlorella pyrenoidosa”. Planta Medica 67.8 (2001): 737-742. https://www.ncbi. nlm.nih.gov/pubmed/11731916
- Suarez ER., et al. “Immunostimulatory polysaccharides from Chlorella pyrenoidosa. A new galactofuranan. measurement of molecu- lar weight and molecular weight dispersion by DOSY NMR”. Biomacromolecules 7.8 (2006): 2368-2376. https://www.ncbi.nlm.nih. gov/pubmed/16903684
- Mao TK., et al. “Effects of a Spirulina-based dietary supplement on cytokine production from allergic rhinitis patients”. Journal of Medicinal Food 8.1 (2005): 27-30. https://www.ncbi.nlm.nih.gov/pubmed/15857205
- Hayashi O., et al. “Class specific influence of dietary Spirulina platensis on antibody production in mice”. Journal of Nutritional Science and Vitaminology 44.6 (1998): 841-851. https://www.ncbi.nlm.nih.gov/pubmed/10197315
- Dodd S., et al. “N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility”. Expert Opinion on Biological Therapy 8.12 (2008): 1955-1962. https://www.ncbi.nlm.nih.gov/pubmed/18990082
- Vazquez-Sanchez J., et al. “Spirulina maxima and its protein extract protect against hydroxyurea-teratogenic insult in mice”. Food and Chemical Toxicology 47.11 (2009): 2785-2759. https://www.ncbi.nlm.nih.gov/pubmed/19703510
- Raijmakers MT., et al. “Oxidative stress and preeclampsia: rationale for antioxidant clinical trials”. Hypertension 44.4 (2004): 374-380. https://www.ncbi.nlm.nih.gov/pubmed/15326082
- Dechend R., et al. “AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase”. Circulation 7.12 (2003): 1632-1639. https://www.ncbi.nlm.nih.gov/pubmed/12668498